XKRX
001790
Market cap160mUSD
Jul 09, Last price
2,795.00KRW
1D
-3.79%
1Q
-6.83%
Jan 2017
16.46%
Name
TS Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1956 and headquartered in Seoul, South Korea, TS Corporation is a diverse enterprise primarily focused on the food industry. Its main activities involve the manufacturing and distribution of a wide range of food products, such as sugar, various foodstuffs, food ingredients, additives, dairy items, raw materials for baking, mixed seasonings, and other agricultural goods. In addition to its food-related business, the company trades in non-ferrous metals. TS Corporation also serves the agricultural sector by providing animal feed, including livestock feed sold under the 'Rainbow' brand. It offers administrative support services, featuring digital tools designed for farm management optimization, and delivers pathology laboratory services that comprise extensive testing, analysis, and diagnostic examinations for agricultural producers. Furthermore, the company ventures into biotechnology, concentrating on the development of nutraceuticals and premium food products engineered to combat aging and mitigate adult diseases. Simultaneously, it undertakes the research, production, and commercialization of two significant biological products: erythropoietin and streptokinase. With a global reach, its products are exported to various international markets, including China, Southeast Asia, and Micronesia.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||